![1]()
News
Triple therapy in question
January 16, 2018
Clinical question: In patients with nonvalvular atrial fibrillation undergoing percutaneous coronary intervention (PCI), is dabigatran plus a P2Y12 inhibitor safer than, and as efficacious as, triple therapy with warfarin?
![1]()
News
Rivaroxaban lowers cardiovascular risk but increases bleeding risk
January 16, 2018
Is rivaroxaban alone or in combination with aspirin more effective than is aspirin alone in preventing cardiovascular events in patients with stable atherosclerotic disease?
News
Check orthostatic vital signs within 1 minute
January 11, 2018
What is the relationship between timing of measurement of postural blood pressure (BP) and adverse clinical outcomes?
![1]()
News
How to manage a patient presenting with syncope
January 4, 2018
Obtaining a detailed history is crucial to determining which patients with syncope are at high risk for adverse outcomes.
![1]()
News
Thrombectomy shines in presence of a clinical deficit and imaging mismatch
January 3, 2018
Less disability, greater functional independence, and less neurologic deterioration was observed for thrombectomy plus standard care.
![1]()
News
Short Takes
December 29, 2017
A brief roundup of HM-centric research.
![1]()
News
ACC guidance addresses newer HFrEF options
December 28, 2017
Opportunities are being missed.
![1]()
News
FDA approves angiotensin II for shock patients
December 28, 2017
Treatment option for critically ill hypotensive patients who do not adequately respond to available therapies.
![1]()
News
Journal of Hospital Medicine – Dec. 2017
December 21, 2017
Read the latest research from the Journal of Hospital Medicine, the premier publication for dissemination of research and education for the specialty of hospital medicine.
![1]()
News
Use of the dual-antiplatelet therapy score to guide treatment duration after percutaneous coronary intervention
December 20, 2017
Clinical question: Can the dual-antiplatelet therapy scoring system be used to determine which patients undergoing percutaneous coronary intervention (PCI) would benefit from prolonged (24 months) DAPT?
